Pharmaceutical public policy
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Book |
| Language: | English |
| Published: |
Boca Raton, Florida :
CRC Press
c2016
|
| Subjects: |
Table of Contents:
- 1. Policy process
- 2. Federal legislative process
- 3. Role of federal regulations and how they are developed
- 4. Access, quality, and cost
- 5. Why is medication use less than appropriate?
- 6. Medication adherence and health policy
- 7. Good governance and corruption in the pharmaceutical system
- 8. U.S. Food and Drug Administration
- 9. Risk minimization: a new regulatory challenge directive
- 10. Drug shortages
- 11. Drug reimportation into the United States
- 12. Competition between brand-name and generic drugs
- 13. Structure and dynamics of the pharmaceutical industry
- 14. Health policy and economic issues in biotechnology and personalized medicine
- 15. Pharmaceutical promotion in the United States
- 16. Health technology assessment
- 17. Pharmacoeconomics as a response to market failure: an international perspective
- 18. Market for pharmaceuticals
- 19. Managed care pharmacy and pharmacy benefit management
- 20. Drug insurance design and management
- 21. Electronic information technology: role in supporting drug use and policy
- 22. Assessing medicare part D after 10 years
- 23. Medicaid
- 24. Medication therapy management services
- 25. The Affordable Care Act: potential impacts on pharmaceutical markets
- 26. Role of government as regulator, payer, and provider of care
- 27. Department of veterans affairs pharmacy programs
- 28. Public health service